Glipizide (Minodiab - Carlo Erba; Glibenese - Pfizer) is a new oral hypoglycaemic sulphonylurea developed in Italy. Like glibenclamide (Daonil, Euglucon), which we discussed last year,1 it is a potent cyclohexylurea derivative claimed to have a low incidence of unwanted effects.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.